Understanding GLP
Course Highlights Discover how combining lifestyle modifications with GLP-1 receptor agonists can improve weight loss, glycemic control, and overall cardiometabolic health Examine the science behind GLP-1 receptor agonists, from their effects on insulin secretion and appetite regulation to next-generation agents like tirzepatide and orforglipron Learn best practices for patient education ...
Advancing Diabetes Care Through GLP-1 RA Education Join us for a dynamic, multi-part educational series designed to equip clinicians with practical strategies for optimizing the use of GLP-1 receptor agonists in type 2 diabetes management.
PDF How Do GLP
GLP-1 receptor agonists approved for chronic weight management among patients who have obesity or overweight and other weight-related conditions — including hypertension, type 2 diabetes, or obstructive sleep apnea — include liraglutide (Saxenda®), semaglutide (Wegovy®), and most recently, tirzepatide (Zepbound®).
Elizabeth Ann Beverly, PhD New information and guidance on glucagon-like peptide-1 receptor agonists ( GLP-1 RAs ), technology considerations, and tailoring disease management to the unique circumstances of individuals living with diabetes were recurring themes among the featured chapters.
What is a GLP
Understanding GLP‑1 receptor agonists Where do GLP-1 receptor agonists fit in with insulin and non-insulin diabetes treatments? There are lots of different pills and injections for people with type 2 diabetes—and a GLP-1 receptor agonist ( RA ) is one you may not have heard of.
GLP-1 receptor agonists and GLP-1/GIP combination therapies have become foundational treatments for type 2 diabetes and obesity. Their benefits now extend well beyond glycemic control and weight loss, with growing evidence supporting their use in the management of steatosis liver disease, obstructive sleep apnea, cardiovascular disease, and chronic kidney disease. Emerging studies even suggest ...
Overview of Glp 1 Ra Education
GLP-1 agonists are a class of medications that can help manage Type 2 diabetes and obesity. They're often injection medications.
Glucagon-like peptide-1 ( GLP-1 ) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ago...
PDF Managing Common GLP 1
Managing GI Side Effects GLP-1 RA mechanisms thought to contribute to GI side effects include delayed gastric emptying; their effects on brain regions that regulate weight, appetite, and nausea; and effects on intestinal motility or secretions with higher dosages increasing the risk of adverse symptoms, indicating a dose-dependent relationship.
Don't miss our upcoming program designed to empower you with essential knowledge and skills in the realm of GLP-1 Receptor Agonists ( GLP1 RAs ). Become adept at identifying clients who stand to benefit most , as well as possible downsides. Moreover, we will explore the vital nutrition and lifestyle implications for clients taking GLP1 RAs , providing you with the tools to optimize their well ...